Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Innovation in Oral Obesity Drug Design: Analyses the transition from conventional weight loss medicines to innovative oral GLP-1 agonists, dual incretin agonists, triple agonists, amylin and small molecule obesity drug classes
Nu bn la chn cc loi vin ung c cha thnh phn hot cht chnh ngun gc t nhin, bn hon ton c th yn tm khi s dng di lu m khng cn lo ngi tc dng ph
Studies report that curcumin increases glutathione S-transferase (GST) activity in the liver
Mechanisms Mediating the Diuretic and Natriuretic Actions of the Incretin Hormone Glucagon-Like Peptide-1
Front Microbiol 8:2280
US$ 22.14
US$ 23.78
US$ 23.27
US$ 24.57
